The DOI matches its Crossref record; 1,273 of the 1,273 references it cites were found in a registry or an index.
The c‐myc Promoter: Still MysterY and Challenge
Abstract
The transcription factor c-Myc is a key regulator of cell proliferation, cell growth, differentiation, and apoptosis. Deregulated c-myc expression possesses a high transformation potential and the proto-oncogene c-myc represents a promising target in anticancer therapy. This review on the c-myc promoter describes its organization, the different levels of its normal regulation (including initiation and elongation of transcription, the dual P1/P2 promoters, chromatin structure, c-Myc autosuppression) as well as its deregulation in Burkitt's lymphoma. Furthermore, it summarizes the many different transcription factors, signal transduction pathways, and feedback loops that activate or repress c-myc transcription. Finally, a concept for regulation of the c-myc promoter in different biological settings, for example, immediate-early induction, constant expression throughout the cell cycle in continuously cycling cells, repression during terminal differentiation and deregulation in cancer, is formulated.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Moreover, β-catenin has been shown to stimulate c-Myc expression by activating the c-Myc promoter, which comprises multiple T cell factor-4 (TCF-4) binding sites.447”
From Recent advances in targeting the “undruggable” proteins: from drug discovery to clinical trials (2023) · cites this paper as [447]
Citations
Cites
3 retracted
Items 801–1,000 of 1,273
The c-ets-1 proto-oncogene has oncogenic activity and is positively autoregulated.
Seth, A., & Papas, T. S. (1990) · PubMed · Cited by 125
Reconstructing MYC: Figure 1.Preprint
Levens, D. (2003) · Genes & Development · doi:10.1101/gad.1095203 · Cited by 125
The role of translation in neoplastic transformation from a pathologist's point of view
Rosenwald, I. B. (2004) · Oncogene · doi:10.1038/sj.onc.1207552 · Cited by 125
A new link between the c-Abl tyrosine kinase and phosphoinositide signalling through PLC-γ1
Plattner, R., Irvin, B. J., Guo, S., Blackburn, K., Kazlauskas, A., Abraham, R. T., York, J. D., & Pendergast, A. M. (2003) · Nature Cell Biology · doi:10.1038/ncb949 · Cited by 125
TFIIH: from transcription to clinic
Egly, J. (2001) · FEBS Letters · doi:10.1016/s0014-5793(01)02458-9 · Cited by 123
Talasz, H., Lindner, H. H., Sarg, B., & Helliger, W. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m505563200 · Cited by 123
RB, the conductor that orchestrates life, death and differentiation
Khidr, L., & Chen, P.-L. (2006) · Oncogene · doi:10.1038/sj.onc.1209612 · Cited by 123
Prolyl isomerase Pin1 as a molecular target for cancer diagnostics and therapeutics
Lu, K. P. (2003) · Cancer Cell · doi:10.1016/s1535-6108(03)00218-6 · Cited by 123
Growth Factors Regulate Heterogeneous Nuclear Ribonucleoprotein K Expression and Function
Mandal, M., Vadlamudi, R. K., Nguyen, D. N., et al. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m008514200 · Cited by 123
Prokipcak, R. D., Herrick, D., & Ross, J. (1994) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(17)37102-8 · Cited by 122
A novel alteration in the structure of an activated c-myc gene in a variant t(2;8) burkitt lymphoma
Taub, R. A., Kelly, K., Battey, J., et al. (1984) · Cell · doi:10.1016/0092-8674(84)90381-7 · Cited by 122
Mithramycin blocks transcriptional initiation of the c-myc P1 and P2 promoters
Snyder, R. C., Ray, R. B., Blume, S. W., et al. (1991) · Biochemistry · doi:10.1021/bi00231a027 · Cited by 122
Expert-Bezançon, A., Caer, J. P. L., & Marie, J. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m201083200 · Cited by 122
Majello, B., Luca, P. D., Suske, G., & Lania, L. (1995) · PubMed · Cited by 122
The beta-catenin binding domain of adenomatous polyposis coli is sufficient for tumor suppression.
Shih, I., Yu, J., He, T., Vogelstein, B., & Kinzler, K. W. (2000) · PubMed · Cited by 121
Drug Targeting of the c-MYC Promoter to Repress Gene Expression via a G-Quadruplex Silencer Element
Hurley, L. H., VonHoff, D. D., Siddiqui-Jain, A., & Yang, D. (2006) · Seminars in Oncology · doi:10.1053/j.seminoncol.2006.04.012 · Cited by 121
Nasi, S., Ciarapica, R., Jucker, R., Rosati, J. D., & Soucek, L. (2001) · FEBS Letters · doi:10.1016/s0014-5793(01)02118-4 · Cited by 121
Defective Interplay of Activators and Repressors with TFIIH in Xeroderma Pigmentosum
Liu, J., Akoulitchev, S., Weber, A., Ge, H., Chuikov, S., Libutti, D. E., Wang, X. W., Conaway, J. W., Harris, C. C., Conaway, R. C., et al. (2001) · Cell · doi:10.1016/s0092-8674(01)00223-9 · Cited by 121
Roussel, M. F., Jn, D., Jl, C., Ghysdael, J., & Hiebert, S. W. (1994) · PubMed · Cited by 121
DesJardins, E., & Hay, N. (1993) · Molecular and Cellular Biology · doi:10.1128/mcb.13.9.5710 · Cited by 121
The CBP co-activator stimulates E2F1/DP1 activity
Trouche, D. (1996) · Nucleic Acids Research · doi:10.1093/nar/24.21.4139 · Cited by 120
Nagl, N. G., Zweitzig, D. R., Thimmapaya, B., Beck, G. R., & Morán, E. (2006) · Cancer Research · doi:10.1158/0008-5472.can-05-3427 · Cited by 120
DeNardo, D. G., Kim, H.-T., Hilsenbeck, S. G., Cuba, V. L., Tsimelzon, A. I., & Brown, P. H. (2004) · Molecular Endocrinology · doi:10.1210/me.2004-0267 · Cited by 120
Levens, D. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.102173199 · Cited by 120
McConnell, M. J., Chevallier, N., Berkofsky‐Fessler, W., Giltnane, J. M., Malani, R. B., Staudt, L. M., & Licht, J. D. (2003) · Molecular and Cellular Biology · doi:10.1128/mcb.23.24.9375-9388.2003 · Cited by 120
Louro, I. D., Bailey, E. C., Li, X., et al. (2002) · PubMed · Cited by 119
MAZ‐dependent termination between closely spaced human complement genes.
Ashfield, R., Patel, A. J., Bossone, S., et al. (1994) · The EMBO Journal · doi:10.1002/j.1460-2075.1994.tb06904.x · Cited by 119
Transcriptional repressor ZF5 identifies a new conserved domain in zina finger proteins
Numoto, M., Niwa, O., Kaplan, J., Wrong, K.-K., Merrell, K. T., Kamiya, K., Yanagihara, K., & Calame, K. L. (1993) · Nucleic Acids Research · doi:10.1093/nar/21.16.3767 · Cited by 119
Mouse Mammary Tumor Virus c-rel Transgenic Mice Develop Mammary Tumors
Romieu, R., Kim, D. W., Shin, S. M., Demicco, E. G., Landesman‐Bollag, E., Seldin, D. C., Cardiff, R. D., & Sonenshein, G. E. (2003) · Molecular and Cellular Biology · doi:10.1128/mcb.23.16.5738-5754.2003 · Cited by 119
Postel, E. H., & Ferrone, C. A. (1994) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(17)37011-4 · Cited by 118
Arsura, M., Mercurio, F., Oliver, A. L., Thorgeirsson, S. S., & Sonenshein, G. E. (2000) · Molecular and Cellular Biology · doi:10.1128/mcb.20.15.5381-5391.2000 · Cited by 118
Fedoroff, O. Y., Rangan, A., Chemeris, V. V., et al. (2000) · Biochemistry · doi:10.1021/bi001528j · Cited by 118
Transcriptional activation of the c-myc gene by the c-myb and B-myb gene products.
Nakagoshi, H., Kanei‐Ishii, C., Sawazaki, T., et al. (1992) · PubMed · Cited by 118
Belandia, B., & Parker, M. G. (2003) · Cell · doi:10.1016/s0092-8674(03)00599-3 · Cited by 117
Protein kinase C-beta is required for macrophage differentiation of human HL-60 leukemia cells.
Tonetti, D. A., Henning-Chubb, C., Yamanishi, D. T., & Huberman, E. (1994) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(17)31643-5 · Cited by 117
Kim, J. Y., Kang, Y.-S., Lee, J.-W., Kim, H. J., Ahn, Y. H., Park, H., Ko, Y., & Kim, S. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.122110199 · Cited by 117
Karlsson, A. E., Giuriato, S., Tang, F. L. M., Weier, J. F., Levan, G., & Felsher, D. W. (2003) · Blood · doi:10.1182/blood-2002-10-3091 · Cited by 117
Transcriptional Regulation by Smads: Crosstalk between the TGF-β and Wnt Pathways
Letamendı́a, A., Labbé, E., & Attisano, L. (2001) · Journal of Bone and Joint Surgery · doi:10.2106/00004623-200100001-00005 · Cited by 117
Role of genetic and epigenetic changes in Burkitt lymphoma
Lindström, M. S., & Wiman, K. G. (2002) · Seminars in Cancer Biology · doi:10.1016/s1044-579x(02)00058-5 · Cited by 116
Suzuki, H., Yagi, K., Kondo, M., Kato, M., Miyazono, K., & Miyazawa, K. (2004) · Oncogene · doi:10.1038/sj.onc.1207690 · Cited by 116
Lee, T.-C., Zhang, Y., & Schwartz, R. J. (1994) · PubMed · Cited by 116
Bellosta, P., Hulf, T., Diop, S. B., Usseglio, F., Pradel, J., Aragnol, D., & Gallant, P. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0408945102 · Cited by 116
Keeton, E., & Brown, M. A. (2005) · Molecular Endocrinology · doi:10.1210/me.2004-0395 · Cited by 115
Sheppard, H. M., Harries, J. C., Hussain, S., Bevan, C. L., & Heery, D. M. (2001) · Molecular and Cellular Biology · doi:10.1128/mcb.21.1.39-50.2001 · Cited by 115
Multiple mechanisms regulate c‐myc gene expression during normal T cell activation.
Lindsten, T., June, C. H., & Thompson, C. B. (1988) · The EMBO Journal · doi:10.1002/j.1460-2075.1988.tb03133.x · Cited by 113
Tian, Y., & Phillips, A. O. (2002) · American Journal Of Pathology · doi:10.1016/s0002-9440(10)61109-1 · Cited by 113
Wang, Y.-Z., Wharton, W., Garcia, R., Kraker, A. J., Jove, R., & Pledger, W. J. (2000) · Oncogene · doi:10.1038/sj.onc.1203548 · Cited by 113
Kobayashi, A., Yamagiwa, H., Hoshino, H., Muto, A., Sato, K., Morita, M., Hayashi, N., Yamamoto, M. P., & Igarashi, K. (2000) · Molecular and Cellular Biology · doi:10.1128/mcb.20.5.1733-1746.2000 · Cited by 112
The structure and nucleotide sequence of the 5' end of the human c-myc oncogene.
Watt, R. A., Nishikura, K., Sorrentino, J., et al. (1983) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.80.20.6307 · Cited by 111
Rosenbaum, H., Webb, E., Adams, J. M., Cory, S., & Harris, A. W. (1989) · The EMBO Journal · doi:10.1002/j.1460-2075.1989.tb03435.x · Cited by 110
Facchini, L. M., Chen, S., Marhin, W. W., Lear, J. N., & Penn, L. Z. (1997) · Molecular and Cellular Biology · doi:10.1128/mcb.17.1.100 · Cited by 110
NF-kappa B-like factors mediate interleukin 1 induction of c-myc gene transcription in fibroblasts.
Kessler, D. J., Duyao, M. P., Spicer, D. B., et al. (1992) · The Journal of Experimental Medicine · doi:10.1084/jem.176.3.787 · Cited by 110
Histone acetylation-mediated regulation of genes in leukaemic cells
Chambers, A., Banerjee, S., Chaplin, T., Dunne, J., Debernardi, S., Joel, S. P., & Young, B. D. (2003) · European Journal of Cancer · doi:10.1016/s0959-8049(03)00072-8 · Cited by 109
An Induced Ets Repressor Complex Regulates Growth Arrest during Terminal Macrophage Differentiation
Klappacher, G., Lunyak, V. V., Sykes, D. B., Sawka‐Verhelle, D., Sage, J., Brard, G., Ngo, S. D., Gangadharan, D., Jacks, T., Kamps, M. P., et al. (2002) · Cell · doi:10.1016/s0092-8674(02)00714-6 · Cited by 109
Pandey, A., Fernandez, M. M., Steen, H., Blagoev, B., Nielsen, M. M., Roche, S., Mann, M., & Lodish, H. F. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.m007849200 · Cited by 109
Siebenlist, U. K., Bressler, P. B., & Kelly, K. (1988) · Molecular and Cellular Biology · doi:10.1128/mcb.8.2.867 · Cited by 108
Kawahara, A., Minami, Y., Miyazaki, T., et al. (1995) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.92.19.8724 · Cited by 108
Jung, C., Kim, R.-S., Lee, S.-J., et al. (2004) · Cancer Research · doi:10.1158/0008-5472.can-03-2614 · Cited by 108
Lin, K., Lin, Y., & Calame, K. L. (2000) · Molecular and Cellular Biology · doi:10.1128/mcb.20.23.8684-8695.2000 · Cited by 108
The Role of C/EBPβ in Mammary Gland Development and Breast Cancer
Grimm, S. L., & Rosen, J. M. (2003) · Journal of Mammary Gland Biology and Neoplasia · doi:10.1023/a:1025900908026 · Cited by 108
Negative autoregulation of c‐myc gene expression is inactivated in transformed cells.
Grignani, F., Lombardi, L. T., Inghirami, G., Sternas, L. A., Cechova, K., & Dalla‐Favera, R. (1990) · The EMBO Journal · doi:10.1002/j.1460-2075.1990.tb07612.x · Cited by 107
A FOS protein is present in a complex that binds a negative regulator of MYC.Preprint
Hay, N., Takimoto, M., & Bishop, J. M. (1989) · Genes & Development · doi:10.1101/gad.3.3.293 · Cited by 107
Smad Transcriptional Corepressors in TGFβ Family Signaling
Wotton, D., & Massagué, J. (2001) · Current topics in microbiology and immunology · doi:10.1007/978-3-662-10595-5_8 · Cited by 107
Rb-mediated chromatin structure regulation and transcriptional repression
Zhang, H. S., & Dean, D. C. (2001) · Oncogene · doi:10.1038/sj.onc.1204338 · Cited by 107
Roles of KLF6 and KLF6-SV1 in Ovarian Cancer Progression and Intraperitoneal Dissemination
DiFeo, A. V., Narla, G., Hirshfeld, J., Camacho‐Vanegas, O., Narla, J., Rose, S. L., Kalir, T., Yao, S., Levine, A. C., Birrer, M. J., et al. (2006) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-06-0054 · Cited by 107
Shichiri, M., Hanson, K. D., & Sedivy, J. M. (1993) · PubMed · Cited by 106
Cell growth inhibition by the multifunctional multivalent zinc-finger factor CTCF.
Rasko, J. E. J., Klenova, E. M., León, J., Filippova, G. N., Loukinov, D. I., Vatolin, S., Robinson, A. F., Hu, Y. J., Ulmer, J., Ward, M. D., et al. (2001) · PubMed · Cited by 106
C/EBPα Regulates Formation of S-Phase-Specific E2F-p107 Complexes in Livers of Newborn Mice
Timchenko, N. A., Wilde, M., & Darlington, G. (1999) · Molecular and Cellular Biology · doi:10.1128/mcb.19.4.2936 · Cited by 106
Grumont, R. J., Lock, P., Mollinari, M., Shannon, F. M., Moore, A., & Gerondakis, S. (2004) · Immunity · doi:10.1016/j.immuni.2004.06.004 · Cited by 106
Fernández-Zapico, M. E., Mladek, A. C., Ellenrieder, V., Folch‐Puy, E., Miller, L., & Urrutia, R. A. (2003) · The EMBO Journal · doi:10.1093/emboj/cdg470 · Cited by 106
Zou, X., Rudchenko, S., Wong, K., & Calame, K. L. (1997) · Genes & Development · doi:10.1101/gad.11.5.654 · Cited by 106
E2F1 and E1A(12S) have a homologous activation domain regulated by RB and CBP.
Trouche, D., & Kouzarides, T. (1996) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.93.4.1439 · Cited by 105
Klenova, E. M., Chernukhin, I. V., Elkady, A. I., Lee, R. E., Pugacheva, E. M., Loukinov, D. I., Goodwin, G. H., Delgado, M. D., Filippova, G. N., León, J., et al. (2001) · Molecular and Cellular Biology · doi:10.1128/mcb.21.6.2221-2234.2001 · Cited by 105
Implication of BRG1 and cdk9 in the STAT3-mediated activation of the p21waf1 gene
Giraud, S., Hurlstone, A. F. L., Avril, S., & Coqueret, O. (2004) · Oncogene · doi:10.1038/sj.onc.1207972 · Cited by 105
Multiple Biochemical Activities of NM23/NDP Kinase in Gene Regulation
Postel, E. H. (2003) · Journal of Bioenergetics and Biomembranes · doi:10.1023/a:1023485505621 · Cited by 104
HOXB13 is downregulated in colorectal cancer to confer TCF4-mediated transactivation
Jung, C., Kim, R.-S., Zhang, H., Lee, S., Sheng, H., Loehrer, P. J., Gardner, T. A., Jeng, M. H., & Kao, C. H. (2005) · British Journal of Cancer · doi:10.1038/sj.bjc.6602631 · Cited by 104
Fowles, L., Martin, M. L., Nelsen, L., Stacey, K. J., Redd, D., Clark, Y. M., Nagamine, Y., McMahon, M., Hume, D. A., & Ostrowski, M. C. (1998) · Molecular and Cellular Biology · doi:10.1128/mcb.18.9.5148 · Cited by 104
CCAAT/enhancer binding proteins in normal mammary development and breast cancer
Zahnow, C. A. (2002) · Breast Cancer Research · doi:10.1186/bcr428 · Cited by 104
Zentella‐Dehesa, A., Weis, F. M., Ralph, D. A., Laiho, M., & Massagué, J. (1991) · Molecular and Cellular Biology · doi:10.1128/mcb.11.10.4952 · Cited by 104
IL-2 Induces STAT4 Activation in Primary NK Cells and NK Cell Lines, But Not in T Cells
Wang, K. S., Ritz, J., & Frank, D. A. (1999) · The Journal of Immunology · doi:10.4049/jimmunol.162.1.299 · Cited by 103
Takimoto, M., Quinn, J. P., Farina, A. R., et al. (1989) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)81892-0 · Cited by 103
Emami, K. H., Jain, A., & Smale, S. T. (1997) · Genes & Development · doi:10.1101/gad.11.22.3007 · Cited by 103
Nuclear receptor cofactors as chromatin remodelers
Lemon, B. D., & Freedman, L. P. (1999) · Current Opinion in Genetics & Development · doi:10.1016/s0959-437x(99)00010-6 · Cited by 103
Tumor Dormancy and MYC Inactivation: Pushing Cancer to the Brink of Normalcy
Shachaf, C. M., & Felsher, D. W. (2005) · Cancer Research · doi:10.1158/0008-5472.can-05-1172 · Cited by 103
c-Myc as a therapeutic target in cancer
Prochownik, E. V. (2004) · Expert Review of Anticancer Therapy · doi:10.1586/14737140.4.2.289 · Cited by 103
Definition of the activities and properties of c-myc required to inhibit cell differentiation.
Freytag, S. O., Dang, C. V., & Lee, W. M. (1990) · PubMed · Cited by 102
Polyamines modulate transcription but not posttranscription of c-myc and c-jun in IEC-6 cells
Patel, A. R., & Wang, J. Y. (1997) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.1997.273.3.c1020 · Cited by 102
Emens, L. A. (2005) · PubMed · Cited by 102
A Point Mutation in the c- myc Locus of a Burkitt Lymphoma Abolishes Binding of a Nuclear Protein
Zajac‐Kaye, M., Gelmann, E. P., & Levens, D. (1988) · Science · doi:10.1126/science.2454510 · Cited by 101
Wasylyk, C., Bradford, A. P., Gutierrez-Hartmann, A., & Wasylyk, B. (1997) · Oncogene · doi:10.1038/sj.onc.1200914 · Cited by 101
Fournier, H.-N., Manet, S., Bouvard, D., Lacombe, M., Marie, C., Block, M. R., & Albigès‐Rizo, C. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m200200200 · Cited by 101
c-myc Expression: Keep the Noise Down!
Chung, H., & Levens, D. (2005) · Molecules and Cells · doi:10.1016/s1016-8478(23)13212-2 · Cited by 101
Oswald, F., Lovec, H., Möröy, T., & Lipp, M. (1994) · PubMed · Cited by 101
Mechanisms of Transcriptional Repression by Myc
Kleine‐Kohlbrecher, D., Adhikary, S., & Eilers, M. (2006) · Springer eBooks · doi:10.1007/3-540-32952-8_3 · Cited by 100
Carbone, G. M. (2004) · Nucleic Acids Research · doi:10.1093/nar/gkh744 · Cited by 100
Tsujiuchi, T., Tsutsumi, M., Sasaki, Y., et al. (1999) · Japanese Journal of Cancer Research · doi:10.1111/j.1349-7006.1999.tb00834.x · Cited by 100
Differential gene regulation by the SRC family of coactivatorsPreprint
Zhang, H., Yi, X., Sun, X., Yin, N., Shi, B., Wu, H., Wang, D., Wu, G., & Shang, Y. (2004) · Genes & Development · doi:10.1101/gad.1194704 · Cited by 100
Shi, L., Dubeykovskiy, A. N., Chakladar, A., Wojtukiewicz, L. J., & Wang, T. C. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m404025200 · Cited by 99
Mechti, N., Piechaczyk, M., Jm, B., et al. (1986) · Nucleic Acids Research · doi:10.1093/nar/14.24.9653 · Cited by 98
Chernukhin, I. V., Shamsuddin, S., Robinson, A. F., Carne, A. F., Paul, A., Elkady, A. I., Lobanenkov, V. V., & Klenova, E. M. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.m001538200 · Cited by 97
Schauer, S. L., Wang, Z., Sonenshein, G. E., et al. (1996) · The Journal of Immunology · doi:10.4049/jimmunol.157.1.81 · Cited by 96
Koyama, Y., Adachi, M., Sekiya, M., Takekawa, M., & Imai, K. (2000) · Blood · doi:10.1182/blood.v96.4.1490 · Cited by 96
C/EBPα: A tumour suppressor in multiple tissues?
Schuster, M. B., & Porse, B. T. (2006) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2006.02.003 · Cited by 96
TIP30 has an intrinsic kinase activity required for up‐regulation of a subset of apoptotic genes
Xiao, H., Palhan, V. B., Yang, Y., & Roeder, R. G. (2000) · The EMBO Journal · doi:10.1093/emboj/19.5.956 · Cited by 96
The interplay between Mad and Myc in proliferation and differentiation
Zhou, Z.-Q., & Hurlin, P. J. (2001) · Trends in Cell Biology · doi:10.1016/s0962-8924(01)02121-3 · Cited by 96
Farris, S. D., Rubio, E. D., Moon, J. J., Gombert, W. M., Nelson, B. H., & Krumm, A. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m501784200 · Cited by 96
Hu, M., & Rosenblum, N. D. (2004) · Development · doi:10.1242/dev.01573 · Cited by 96
Smale, S. T., JAIN, A., KAUFMANN, J., et al. (1998) · Cold Spring Harbor Symposia on Quantitative Biology · doi:10.1101/sqb.1998.63.21 · Cited by 96
Effects of c-myc expression on cell cycle progression.
Hanson, K. D., Shichiri, M., Follansbee, M. R., et al. (1994) · Molecular and Cellular Biology · doi:10.1128/mcb.14.9.5748 · Cited by 96
Activation by c-Myc of transcription by RNA polymerases I, II and III
Gomez-Roman, N., Felton-Edkins, Z. A., Kenneth, N. S., Goodfellow, S. J., Athineos, D., Zhang, J., Ramsbottom, B. A., Innes, F., Kantidakis, T., Kerr, E. R., et al. (2006) · Biochemical Society Symposia · doi:10.1042/bss0730141 · Cited by 95
Levy-Strumpf, N., Yonish-Rouach, E., Oren, M., & Kimchi, A. (1993) · Molecular and Cellular Biology · doi:10.1128/mcb.13.12.7942-7952.1993 · Cited by 95
Penn, L. Z., Brooks, M. W., Laufer, E., Littlewood, T. D., Morgenstern, J. P., Evan, G. I., Lee, W. M., & Land, H. (1990) · Molecular and Cellular Biology · doi:10.1128/mcb.10.9.4961 · Cited by 95
Piek, E., & Roberts, A. B. (2001) · Advances in cancer research · doi:10.1016/s0065-230x(01)83001-3 · Cited by 94
Dejgaard, K., Leffers, H. C. B., Rasmussen, H. H., et al. (1994) · Journal of Molecular Biology · doi:10.1006/jmbi.1994.1116 · Cited by 93
The human cut homeodomain protein represses transcription from the c-myc promoter.
Dufort, D., & Nepveu, A. (1994) · Molecular and Cellular Biology · doi:10.1128/mcb.14.6.4251 · Cited by 92
Heruth, D. P., Zirnstein, G. W., Bradley, J. F., et al. (1993) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(20)80749-2 · Cited by 91
Src Family Kinases Are Required for Prolactin Induction of Cell Proliferation
Vara, J. Á. F., Cáceres, M. A. D., Silva, A., & Martı́n-Pérez, J. (2001) · Molecular Biology of the Cell · doi:10.1091/mbc.12.7.2171 · Cited by 91
Mechanism of c-myc Regulation by c-Myb in Different Cell Lineages
Cogswell, J. P., Cogswell, P. C., Kuehl, W. M., Cuddihy, A. M., Bender, T. M., Engelke, U., Marcu, K. B., & Ting, J. P. ‐. (1993) · Molecular and Cellular Biology · doi:10.1128/mcb.13.5.2858 · Cited by 91
Notch signaling in hematopoiesis and early lymphocyte development
Allman, D., Aster, J. C., & Pear, W. S. (2002) · Immunological Reviews · doi:10.1034/j.1600-065x.2002.18707.x · Cited by 90
Quaternary Structure of Nucleoside Diphosphate Kinases
Lascu, I., GIARTOSIO, A., Ransac, S., & Erent, M. (2000) · Journal of Bioenergetics and Biomembranes · doi:10.1023/a:1005580828141 · Cited by 89
Madisen, L., Krumm, A., Hebbes, T. R., & Groudine, M. T. (1998) · Molecular and Cellular Biology · doi:10.1128/mcb.18.11.6281 · Cited by 89
A Direct β-Catenin-independent Interaction between Androgen Receptor and T Cell Factor 4
Amir, A. L., Barua, M., McKnight, N. C., Cheng, S., Yuan, X., & Balk, S. P. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m301208200 · Cited by 89
Overexpression of the beta 1 thyroid receptor induces differentiation in neuro-2a cells.
Lebel, J., Dussault, J. H., & Puymirat, J. (1994) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.91.7.2644 · Cited by 89
Demicco, E. G., Kavanagh, K. T., Romieu, R., Wang, X., Shin, S. R., Landesman‐Bollag, E., Seldin, D. C., & Sonenshein, G. E. (2005) · Molecular and Cellular Biology · doi:10.1128/mcb.25.22.10136-10147.2005 · Cited by 89
Telomerase inhibition and cell growth arrest by G-quadruplex interactive agent in multiple myeloma.
Shammas, M. A., Reis, R. J. S., Akiyama, M., Koley, H., Chauhan, D., Hideshima, T., Goyal, R. K., Hurley, L. H., Anderson, K. C., & Munshi, N. C. (2003) · PubMed · Cited by 88
DNA sequences that mediate attenuation of transcription from the mouse protooncogene myc.
Wright, S. C., & Bishop, J. M. (1989) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.86.2.505 · Cited by 88
RNAs induced by Epstein–Barr virus nuclear antigen 2 in lymphoblastoid cell lines
Zhao, B., Maruo, S., Cooper, A., Chase, M. R., Johannsen, E., Kieff, E. D., & Cahir-McFarland, E. D. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0510612103 · Cited by 88
Spencer, C. A., Lestrange, R. C., Novak, U., Hayward, W. S., & Groudine, M. T. (1990) · Genes & Development · doi:10.1101/gad.4.1.75 · Cited by 88
Functional analysis of the N-terminal domain of the Myc oncoprotein
Oster, S. K., Mao, D. Y. L., Kennedy, J. L., et al. (2003) · Oncogene · doi:10.1038/sj.onc.1206228 · Cited by 87
Ellenrieder, V., Buck, A., Harth, A. J., Jungert, K., Buchholz, M., Adler, G., Urrutia, R. A., & Gress, T. M. (2004) · Gastroenterology · doi:10.1053/j.gastro.2004.05.018 · Cited by 86
Yang, X., Liu, D., Murray, T. J., Mitchell, G. C., Hestermann, E. V., Karchner, S. I., Merson, R. R., Hahn, M. E., & Sherr, D. H. (2005) · Oncogene · doi:10.1038/sj.onc.1208938 · Cited by 86
Wang, X., Hung, N., & Costa, R. H. (2001) · Hepatology · doi:10.1053/jhep.2001.24666 · Cited by 86
Pérez-Juste, G., & Aranda, A. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.8.5026 · Cited by 86
Lord, J. D., McIntosh, B. C., Greenberg, P. D., & Nelson, B. H. (1998) · The Journal of Immunology · doi:10.4049/jimmunol.161.9.4627 · Cited by 86
Matsushita, K., Tomonaga, T., Shimada, H., Shioya, A., Higashi, M., Matsubara, H., Harigaya, K., Nomura, F., Libutti, D. E., Levens, D., et al. (2006) · Cancer Research · doi:10.1158/0008-5472.can-04-4459 · Cited by 86
Filmus, J., Zhao, J., & Rn, B. (1992) · PubMed · Cited by 86
Medrano, E. E. (2003) · Oncogene · doi:10.1038/sj.onc.1206452 · Cited by 86
Domínguez-Cáceres, M. A., García-Martínez, J. M., Calcabrini, A., González, L., González‐Porqué, P., León, J., & Martı́n-Pérez, J. (2004) · Oncogene · doi:10.1038/sj.onc.1208002 · Cited by 86
Hoover, R. R., Gerlach, M. J., Koh, E. Y., et al. (2001) · Oncogene · doi:10.1038/sj.onc.1204549 · Cited by 86
Toualbi, K., Guller, M. C., Mauriz, J. L., Labalette, C., Buendia, M., Mauviel, A., & Bernuau, D. (2006) · Oncogene · doi:10.1038/sj.onc.1210133 · Cited by 85
The Mad Side of the Max Network: Antagonizing the Function of Myc and More
Rottmann, S., & Lüscher, B. (2006) · Springer eBooks · doi:10.1007/3-540-32952-8_4 · Cited by 84
Thyroid hormone‐regulated enhancer blocking: cooperation of CTCF and thyroid hormone receptor
Lutz, M., Burke, L. J., LeFevre, P., Myers, F. A., Thorne, A. W., Crane‐Robinson, C., Bonifer, C., Filippova, G. N., Lobanenkov, V. V., & Renkawitz, R. (2003) · The EMBO Journal · doi:10.1093/emboj/cdg147 · Cited by 84
Li, T.-F., Chen, D., Wu, Q., et al. (2006) · Journal of Biological Chemistry · doi:10.1074/jbc.m600514200 · Cited by 84
Etard, C., Gradl, D., Kunz, M., Eilers, M., & Wedlich, D. (2004) · Mechanisms of Development · doi:10.1016/j.mod.2004.11.010 · Cited by 84
Deregulation of NF-κB and its upstream kinases in cancer
Sun, S.-C., & Xiao, G. (2003) · Cancer and Metastasis Reviews · doi:10.1023/a:1023733231406 · Cited by 83
Ji, L., Arcinas, M., & Boxer, L. M. (1995) · Journal of Biological Chemistry · doi:10.1074/jbc.270.22.13392 · Cited by 83
Evans, J. L., Moore, T. L., Kuehl, W. M., Bender, T. M., & Ting, J. P. ‐. (1990) · Molecular and Cellular Biology · doi:10.1128/mcb.10.11.5747 · Cited by 83
Riggs, K. J., Merrell, K. T., Wilson, G., et al. (1991) · Molecular and Cellular Biology · doi:10.1128/mcb.11.3.1765 · Cited by 83
Identification of the human erythropoietin receptor region required for Stat1 and Stat3 activation
Kirito, K., Nakajima, K., Watanabe, T., Uchida, M., Tanaka, M., Ozawa, K., & Komatsu, N. (2002) · Blood · doi:10.1182/blood.v99.1.102 · Cited by 82
NFAT transcription factors: from cell cycle to tumor development
Viola, J. P. B., Carvalho, L. D. S., Fonseca, B. D. P. F. E., & Teixeira, L. K. (2005) · Brazilian Journal of Medical and Biological Research · doi:10.1590/s0100-879x2005000300003 · Cited by 82
Hooker, C. W., & Hurlin, P. J. (2006) · Journal of Cell Science · doi:10.1242/jcs.02815 · Cited by 81
DNA Tetraplex Formation Studied with Fluorescence Resonance Energy Transfer
Simonsson, T., & Sjöback, R. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.24.17379 · Cited by 81
Cook, T. A., & Urrutia, R. A. (2000) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.2000.278.4.g513 · Cited by 81
Transcriptional Activation by the Myc Oncoprotein
Cole, M. D., & Nikiforov, M. A. (2006) · Springer eBooks · doi:10.1007/3-540-32952-8_2 · Cited by 80
A human NDP-kinase B specifically binds single-stranded poly-pyrimidine sequences
Hildebrandt, M., Lacombe, M., Mesnildrey, S., et al. (1995) · Nucleic Acids Research · doi:10.1093/nar/23.19.3858 · Cited by 80
c-ets-2 protooncogene has mitogenic and oncogenic activity.
Seth, A. K., Watson, D. K., Blair, D. G., et al. (1989) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.86.20.7833 · Cited by 80
Signal transducer and activator of transcription 5 (STAT5)
Buitenhuis, M., Coffer, P. J., & Koenderman, L. (2004) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/j.biocel.2003.11.008 · Cited by 80
The c- myc Insulator Element and Matrix Attachment Regions Definethe c- myc ChromosomalDomain
Gombert, W. M., Farris, S. D., Rubio, E. D., Morey-Rosler, K. M., Schubach, W. H., & Krumm, A. (2003) · Molecular and Cellular Biology · doi:10.1128/mcb.23.24.9338-9348.2003 · Cited by 80
Iwama, A., Pan, J., Zhang, P., Reith, W., Mach, B., Tenen, D. G., & Sun, Z. (1999) · Molecular and Cellular Biology · doi:10.1128/mcb.19.6.3940 · Cited by 80
Myc degradation: Dancing with ubiquitin ligases
Amati, B. B. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0403046101 · Cited by 79
Pérez-Juste, G., Garcı́a-Silva, S., & Aranda, A. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.275.2.1307 · Cited by 79
Molecular requirements for transcriptional initiation of the murine c-myc gene.
Asselin, C., Nepveu, A., & Kb, M. (1989) · PubMed · Cited by 79
Yang, J. D., Bauer, S. R., Mushinski, J. F., et al. (1985) · The EMBO Journal · doi:10.1002/j.1460-2075.1985.tb03800.x · Cited by 78
E-cadherin is a novel transcriptional target of the KLF6 tumor suppressor
DiFeo, A. V., Narla, G., Camacho‐Vanegas, O., Nishio, H., Rose, S. L., Buller, R. E., Friedman, S. L., Walsh, M. J., & Martignetti, J. A. (2006) · Oncogene · doi:10.1038/sj.onc.1209611 · Cited by 78
Reversibility of oncogene-induced cancer
Felsher, D. W. (2003) · Current Opinion in Genetics & Development · doi:10.1016/j.gde.2003.12.008 · Cited by 78
The prolyl isomerase Pin1 in breast development and cancer
Wulf, G. M., Ryo, A., Liou, Y., & Lu, K. P. (2003) · Breast Cancer Research · doi:10.1186/bcr572 · Cited by 78
Hoechst 33258 binds to G-quadruplex in the promoter region of human c-myc
Maiti, S., Chaudhury, N. K., & Chowdhury, S. (2003) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2003.09.052 · Cited by 78
Tumour suppressor retinoblastoma protein Rb: A transcriptional regulator
Zhu, L. (2005) · European Journal of Cancer · doi:10.1016/j.ejca.2005.08.009 · Cited by 77
STAM2, a new member of the STAM family, binding to the Janus kinases
Endo, K., Takeshita, T., Kasai, H., et al. (2000) · FEBS Letters · doi:10.1016/s0014-5793(00)01760-9 · Cited by 77
c-Myc in the Controlm of Cell Proliferation and Embryonic Development
Lemaı̂tre, J.-M., Buckle, R. S., & Méchali, M. (1996) · Advances in cancer research · doi:10.1016/s0065-230x(08)60873-8 · Cited by 76
Chandramohan, V., Jeay, S., Pianetti, S., & Sonenshein, G. E. (2004) · The Journal of Immunology · doi:10.4049/jimmunol.172.9.5522 · Cited by 76
Transcriptional activation of c-myc proto-oncogene by WT1 protein
Han, Y., San‐Marina, S., Liu, J., & Minden, M. D. (2004) · Oncogene · doi:10.1038/sj.onc.1207609 · Cited by 76
Postel, E. H., Weiss, V. H., Beneken, J., et al. (1996) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.93.14.6892 · Cited by 76
c-Myc, Genome Instability, and Tumorigenesis: The Devil Is in the Details
Wade, M. R., & Wahl, G. M. (2006) · Springer eBooks · doi:10.1007/3-540-32952-8_7 · Cited by 75
Apoptosis in Burkitt lymphoma cells is driven by c-myc.
Milner, A. E., Grand, R. J. A., Waters, C. M., et al. (1993) · PubMed · Cited by 75
The zinc-finger protein CNBP is required for forebrain formation in the mouse
Chen, W., Liang, Y., Deng, W., Shimizu, K., Ashique, A. M., Li, E., & Li, Y. (2003) · Development · doi:10.1242/dev.00349 · Cited by 75
Transcription Reinitiation Rate: a Special Role for the TATA Box
Yean, D., & Gralla, J. D. (1997) · Molecular and Cellular Biology · doi:10.1128/mcb.17.7.3809 · Cited by 74
Postel, E. H. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.32.22821 · Cited by 74
Hoopes, B. C., LeBlanc, J. F., & Hawley, D. K. (1998) · Journal of Molecular Biology · doi:10.1006/jmbi.1998.1651 · Cited by 73
Jiang, C. Y., Ito, M., Piening, V., Bruck, K., Roeder, R. G., & Xiao, H. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m401809200 · Cited by 73
Nepveu, A., Marcu, K. B., Skoultchi, A. I., & Lachman, H. M. (1987) · Genes & Development · doi:10.1101/gad.1.9.938 · Cited by 73
Regulation of Differentiation by HBP1, a Target of the Retinoblastoma Protein
Shih, H. H., Tevosian, S. G., & Yee, A. S. (1998) · Molecular and Cellular Biology · doi:10.1128/mcb.18.8.4732 · Cited by 73
Qi, C., Mårtensson, A., Mattioli, M., Dalla‐Favera, R., Lobanenkov, V. V., & Morse, H. C. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0237127100 · Cited by 73
Targeted Melting and Binding of a DNA Regulatory Element by a Transactivator of c-myc
Bazar, L. S., Meighen, D. L., Harris, V., et al. (1995) · Journal of Biological Chemistry · doi:10.1074/jbc.270.14.8241 · Cited by 72
Uncoupling Raf1 from MEK1/2 Impairs Only a Subset of Cellular Responses to Raf Activation
Pearson, G. W., Bumeister, R., Henry, D. O., Cobb, M. H., & White, M. A. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.c000570200 · Cited by 72
mTOR and cancer: reason for dancing at the crossroads?
THOMAS, G. V. (2005) · Current Opinion in Genetics & Development · doi:10.1016/j.gde.2005.12.003 · Cited by 72
Chen, S., Wulf, G. M., Zhou, X. Z., Rubin, M. A., Lu, K. P., & Balk, S. P. (2006) · Molecular and Cellular Biology · doi:10.1128/mcb.26.3.929-939.2006 · Cited by 72
Timchenko, N. A. (1998) · Nucleic Acids Research · doi:10.1093/nar/26.13.3293 · Cited by 72
DUNCAN, R. C., Collins, I. J., Tomonaga, T., et al. (1996) · Molecular and Cellular Biology · doi:10.1128/mcb.16.5.2274 · Cited by 72
Regulation of the transcription factor, CTCF, by phosphorylation with protein kinase CK2
Elkady, A. I., & Klenova, E. M. (2005) · FEBS Letters · doi:10.1016/j.febslet.2005.01.044 · Cited by 71
Common mechanisms for the control of eukaryotic transcriptional elongation
Krumm, A., Meulia, T., & Groudine, M. T. (1993) · BioEssays · doi:10.1002/bies.950151005 · Cited by 71
Miller, H. I., Asselin, C., Dufort, D., et al. (1989) · Molecular and Cellular Biology · doi:10.1128/mcb.9.12.5340 · Cited by 70
FBPs Are Calibrated Molecular Tools To Adjust Gene Expression
Chung, H., Liu, J., Dundr, M., Nie, Z., Sanford, S., & Levens, D. (2006) · Molecular and Cellular Biology · doi:10.1128/mcb.00754-06 · Cited by 70
Chromatin structure of transcriptionally active and inactive human c‐myc alleles.
Dyson, P. J., Littlewood, T. D., Forster, A. M., et al. (1985) · The EMBO Journal · doi:10.1002/j.1460-2075.1985.tb04018.x · Cited by 69
Release from G1 growth arrest by transforming growth factor beta 1 requires cellular ras activity.
Howe, P. H., Dobrowolski, S. F., Reddy, K. B., & Stacey, D. W. (1993) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)36945-5 · Cited by 69
4-hydroxynonenal and regulation of cell cycle: effects on the pRb/E2F pathway
Barrera, G., Pizzimenti, S., & Dianzani, M. U. (2004) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2004.05.023 · Cited by 69
Transcription factor FOXM1c is repressed by RB and activated by cyclin D1/Cdk4
Wierstra, I., & Alves, J. (2006) · Biological Chemistry · doi:10.1515/bc.2006.119 · Cited by 69
Self-citationDuncan, D. D., Stupakoff, A., Hedrick, S. Μ., Marcu, K. B., & Siu, G. (1995) · Molecular and Cellular Biology · doi:10.1128/mcb.15.6.3179 · Cited by 69
Kihara-Negishi, F., Yamamoto, H., Suzuki, M., Yamada, T., Sakurai, T., Tamura, T., & Oikawa, T. (2001) · Oncogene · doi:10.1038/sj.onc.1204756 · Cited by 69
Research works printed but not linked: 3
- Bareket‐Samish, 2000, Signals for TBP/TATA‐box recognition, J. Mol. Biol., 299, 965
- Liu, 2006, Making Myc, Curr. Top. Microbiol. Immunol., 302, 1
- Skokowa, 2006, LEF‐1 is crucial for neutrophil granulocytopoiesis and its expression is severely reduced in congenital neutropenia, Nat. Med., 12, 1191, 10.1038/nm1474 · DOI
Cited by
Sorted by citations
Duncan, J. S., Whittle, M. C., Nakamura, K., Abell, A. N., Midland, A. A., Zawistowski, J. S., Johnson, N. L., Granger, D. A., Jordan, N. V., Darr, D. B., et al. (2012) · Cell · doi:10.1016/j.cell.2012.02.053 · Cited by 732
MYC: Connecting selective transcriptional control to global RNA production
Kress, T. R., Sabò, A., & Amati, B. (2015) · Nature reviews. Cancer · doi:10.1038/nrc3984 · Cited by 521
An Overview of MYC and Its Interactome
Conacci-Sorrell, M., McFerrin, L., & Eisenman, R. N. (2014) · Cold Spring Harbor Perspectives in Medicine · doi:10.1101/cshperspect.a014357 · Cited by 408
Recent advances in targeting the “undruggable” proteins: from drug discovery to clinical trials
Xie, X., Yu, T., Li, X., Zhang, N., Foster, L. J., Peng, C., Huang, W., & He, G. (2023) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-023-01589-z · Cited by 396
Carabet, L. A., Rennie, P. S., & Cherkasov, A. (2018) · International Journal of Molecular Sciences · doi:10.3390/ijms20010120 · Cited by 172
“While being essential for normal Myc regulation in minimizing undesired Myc expression, the integrated biological output from the multiple-input signaling networks poses the risks of driving pathological conditions [33].”
BackgroundInfluential
Metadata
- Authors
- Wierstra, I., & Alves, J.
- Affiliations
- Medizinische Hochschule Hannover (DE)
- Corresponding author
- Inken Wierstra
- Venue
- Advances in Cancer Research
- Publisher
- Elsevier
- Published
- 2008
- Volume
- 99
- Pages
- 113-333
- ISSN
- 0065-230X (ISSN-L)
- OpenAlex
- W1870041030
- Cited by
- 211
- References
- 1,273
- Citations by year
- 2025: 6 · 2024: 5 · 2023: 9 · 2022: 8 · 2021: 9 · 2020: 18 · 2019: 12 · 2018: 11 · 2017: 16 · 2016: 11 · 2015: 9 · 2014: 12 · 2013: 17 · 2012: 13
- FWCI
- 15.49
- Type
- book chapter
- Language
- en
- Open access
- closed
- Locations
- Advances in cancer research (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Genomics and Chromatin Dynamics
- Health Sciences › Medicine › Oncology › Cancer-related Molecular Pathways
- Health Sciences › Medicine › Pathology and Forensic Medicine › Lymphoma Diagnosis and Treatment
- Keywords
- c-Myc, c-myc promoter, transcriptional regulation, chromatin structure, Burkitt lymphoma, proto-oncogenes, signaling pathways, transcription factors, cell cycle, terminal differentiation
- MeSH terms
- Proto-Oncogene Mas, Animals, Burkitt Lymphoma, Chromatin, Gene Expression Regulation, Humans, Neoplasms, Promoter Regions, Genetic, Proto-Oncogenes, Repressor Proteins, Transcription Factors, Signal Transduction, Genes, myc
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review